Related Experiment Video
Updated: Jul 10, 2026

Implementation of Portable Emissions Measurement Systems (PEMS) for the Real-driving Emissions (RDE) Regulation in Europe
Published on: December 4, 2016
Empowering the demand side: from regulation to purchasing
1Department of Community and Family Medicine, University of California, San Diego.
Private insurance competition has failed to improve healthcare quality or cost-efficiency. Regulation must shift from financial oversight to an active purchasing authority to foster managed competition and reward high-value care providers.
Area of Science:
- Health economics
- Healthcare policy
- Insurance regulation
Background:
- Private insurance is theorized to enhance healthcare quality and efficiency through competition.
- Current market dynamics show this competition has not achieved its intended goals.
- Existing regulatory frameworks primarily focus on insurer financial solvency.
Purpose of the Study:
- To analyze the shortcomings of current private health insurance competition.
- To propose a regulatory shift towards an active purchasing authority.
- To foster a managed competition environment that prioritizes quality and economy in healthcare.
Main Methods:
- Review of current health insurance regulation.
- Analysis of the competitive dynamics within the private insurance market.
- Argument for a transition from passive solvency regulation to active purchasing authority.
Main Results:
- Competition among private insurers has not successfully driven improvements in care quality or economy.
- Current regulatory approaches are insufficient to achieve desired market outcomes.
- An active purchasing authority is presented as a necessary mechanism for change.
Conclusions:
- Transforming passive solvency regulation into an active purchasing authority is crucial.
- This shift would empower consumers and create managed competition.
- Rewarding providers of high-quality, economical care is achievable through this new regulatory model.
Related Concept Videos
Persuasion Strategies
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Global Regulatory Systems
Self-Regulation
Applications of Integration to Find Consumer Surplus

